Factors affecting the adequacy of lymph node yield in prophylactic unilateral central neck dissection for papillary thyroid carcinoma

Journal of Surgical Oncology

Volumn 106, Issue 8, 2012, Pages 966-971

  Lang, Brian Hung Hin ^a   Yih, Patricia Chun Ling ^a   Shek, Tony W H ^a   Wan, Koon Yat ^b   Wong, Kai Pun ^a   Lo, Chung Yau ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

lymph node metastasis; lymph node yield; neck dissection; thyroid carcinoma; thyroidectomy

Indexed keywords

THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CANCER STAGING; CHILD; CLINICAL FEATURE; FEMALE; HUMAN; HYPOPARATHYROIDISM; INDEPENDENT VARIABLE; LYMPH NODE YIELD; LYMPHATIC PARAMETERS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLACTIC CENTRAL NECK DISSECTION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; TUMOR RECURRENCE; VOCAL CORD PARALYSIS; WORK EXPERIENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NECK DISSECTION; PROGNOSIS; PROSPECTIVE STUDIES; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84869489589     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23201     Document Type: Article

References (33)

1. Cancer incidence and mortality in Hong Kong 1983-2008: Hong Kong Cancer Registry, Hong Kong. Available: http://www3.ha.org.hk/cancereg/e-stat.asp [Accessed on 15th September 2011].
2. Lang BH, Lo CY, Chan WF, et al.: Prognostic factors in papillary and follicular thyroid carcinoma: Implications for cancer staging. Ann Surg Oncol 2007; 14: 730-738.
3. Machens A, Hauptmann S, Dralle H,: Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery 2009; 145: 176-181.
4. Johnson PM, Porter GA, Ricciardi R, et al.: Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24: 3570-3575.
5. Schwarz RE, Smith DD,: Extent of lymph node retrieval and pancreatic cancer survival: Information from a large US population database. Ann Surg Oncol 2006; 13: 1189-1200.
6. Bogoevski D, Onken F, Koenig A, et al.: Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 2008; 247: 633-641.
7. Leggett MD, Chen SL, Schneider PD, et al.: Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol 2008; 15: 2493-2499.
8. Beal SH, Chen SL, Schneider PD, et al.: An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg 2010; 76: 28-32.
9. Low TH, Delbridge L, Sidhu SB, et al.: Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer. Ann Surg Oncol 2008; 15: 2827-2832.
10. Lang BH, Wong KP, Wan KY, et al.: Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol 2012; 19: 60-67.
11. Kloos RT, Mazzaferri EL,: A single recombinant human thyrotrophin- stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 2005; 90: 5047-5057.
12. Castagna MG, Brilli L, Pilli T, et al.: Limited value of repeat recombinant thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J Clin Endocrinol Metab 2008; 93: 76-81.
13. Cooper DS, Doherty GM, Hauger BR, et al.: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
14. Moo TA, McGill J, Allendorf J, et al.: Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 2010; 34: 1187-1191.
15. Zetoune T, Keutgen X, Buitrago D, et al.: Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: A meta-analysis. Ann Surg Oncol 2010; 17: 3287-3293.
16. Sywak M, Cornford L, Roach P, et al.: Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid carcinoma. Surgery 2006; 140: 1000-1007.
17. Roh JL, Kim JM, Park CI,: Central lymph node metastasis of unilateral papillary thyroid carcinoma: Patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 2011; 18: 2245-2250.
18. Lang BH, Wong KP, Wan KY, et al.: Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann Surg Oncol 2012; 19: 1257-1263.
19. So YK, Seo MY, Son YI,: Prophylactic central lymph nodes dissection for clinically node-negative papillary thyroid microcarcinoma: Influence on serum thyroglobulin level, recurrence rate, and postoperative complication. Surgery 2012; 148: 526-531.
20. Hughes DT, White ML, Miller BS, et al.: Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 2010; 148: 1100-1107.
21. Bonnet S, Hartl D, Leboulleux S, et al.: Prophylactic lymph node dissection for papillary thyroid cancer less than 2cm: Implications for radioiodine treatment. J Clin Endocrinol Metab 2009; 94: 1162-1167.
22. Carty SE, Cooper DS, Doherty GM, et al.: Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009; 19: 1153-1158.
23. Hartl DM, Leboulleux S, Al Ghuzlan A, et al.: Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 2012; 255: 777-783.
24. Lang BH, Lo CY, Chan WF, et al.: Staging systems for papillary thyroid carcinoma: A review and comparison. Ann Surg 2007; 245: 366-378.
25. Chan WF, Lang BH, Lo CY,: The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: A comparative study on 1000 nerves at risk. Surgery 2006; 140: 866-873.
26. Podnos YD, Smith D, Wagman LD, et al.: The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 2005; 71: 731-734.
27. Zaydfudim V, Feurer ID, Griffin MR, et al.: The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008; 144: 1070-1077; discussion 1077-1078.
28. Lundgren CI, Hall P, Dickman PW, et al.: Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 2006; 106: 524-531.
29. Robbins KT, Shaha AR, Medina JE, et al.: Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008; 134: 536-538.
30. Thorn CC, Woodcock NP, Scott N, et al.: What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis 2004; 6: 356-361.
31. Bamboat ZM, Deperalta D, Dursun A, et al.: Factors affecting lymph node yield from patients undergoing colectomy for cancer. Int J Colorectal Dis 2011; 26: 1163-1168.
32. Nash GM, Row D, Weiss A, et al.: A predictive model for lymph node yield in colon cancer resection specimens. Ann Surg 2011; 253: 318-322.
33. Hayn MH, Hellenthal NJ, Hussain A, et al.: Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium. Urology 2010; 76: 1111-1116.